Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Vaccinations01:51

Vaccinations

Overview
Chickenpox01:20

Chickenpox

Chickenpox is an acute, highly contagious disease caused by the varicella-zoster virus (VZV), a double-stranded DNA virus belonging to the Herpesviridae family. Its transmission occurs primarily through the inhalation of respiratory droplets or direct contact with vesicular fluid from skin lesions. The incubation period typically ranges from 10 to 21 days, during which the virus replicates and disseminates through sequential phases within the host. Although generally self-limiting in children,...
Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary HPV Testing for Cervical Cancer Screening Among Family Medicine Educators.

Journal of the American Board of Family Medicine : JABFM·2026
Same author

Corrigendum to "Black US women share their experiences with follow-up after abnormal cervical cancer screening" [(2025) 100658 10].

Public health in practice (Oxford, England)·2026
Same author

Cervical cancer screening intervals extendable to ten years for 9v HPV vaccinated persons.

Lancet regional health. Americas·2026
Same author

Cervical Cancer Screening and Prevention among Latinas in the United States among a Network of Community Health Centers.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Serious Illness Communication Training in Family Medicine Residencies: A National Study of Program Director Perspectives.

Family medicine·2026
Same author

Rethinking how research is reviewed and published.

eLife·2026
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Related Experiment Video

Updated: Jul 3, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Age for HPV vaccination.

Diane M Harper1, Jorma Paavonen

  • 1Dartmouth College, Department of Women's and Gender Studies, Obstetrics and Gynecology, Community and Family Medicine, Hanover, NH, USA. Diane.M.Harper@Dartmouth.edu

Vaccine
|July 22, 2008
PubMed
Summary
This summary is machine-generated.

Human papillomavirus (HPV) vaccination is effective for girls and may reduce cervical cancer rates. However, the duration of protection is unknown, and screening remains essential.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Experiment Videos

Last Updated: Jul 3, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Area of Science:

  • Gynecologic Oncology
  • Vaccinology
  • Public Health

Background:

  • Cervical cancer remains a significant global health concern.
  • Human papillomavirus (HPV) is the primary cause of cervical cancer.
  • Current HPV vaccines offer protection against high-risk HPV types.

Purpose of the Study:

  • To evaluate the effectiveness of HPV vaccination in pre-pubescent girls.
  • To assess the potential impact of HPV vaccination on cervical cancer rates in women.
  • To review the current understanding of HPV vaccine duration and the need for boosters.

Main Methods:

  • Review of existing clinical data on HPV vaccine efficacy.
  • Analysis of epidemiological trends in cervical cancer.
  • Assessment of current vaccination guidelines and recommendations.

Main Results:

  • HPV vaccination is effective for pre-pubescent girls.
  • Vaccinating older girls and women may expedite cervical cancer rate reduction.
  • Current HPV vaccines are effective for at least 5 years against HPV 16/18-associated precancerous lesions, but long-term duration is unknown.
  • The necessity of booster shots is undetermined.

Conclusions:

  • HPV vaccination is a valuable tool but not a sole solution for cervical cancer elimination.
  • Continued cervical cancer screening is crucial for all women, irrespective of vaccination status.
  • Further research is needed to determine the long-term duration of HPV vaccine protection and the potential need for booster doses.